Table 4.
Reporting adherence over time.
| Week 1 (%) | Week 2 (%) | Week 3 (%) | Week 4 (%) | Week 5 (%) | Week 6 (%) | Week 7 (%) | Week 8 (%) | Average (%) | |
|---|---|---|---|---|---|---|---|---|---|
| MS PRO tool | |||||||||
| Intervention group | 93 | 100 | 93 | 93 | 93 | 93 | 93 | 100 | 95 |
| Control group | 92 | 85 | 92 | 85 | 100 | 85 | 85 | 92 | 89 |
| Fitbit | |||||||||
| Intervention group | 93 | 93 | 93 | 86 | 93 | 93 | 100 | 93 | 93 |
| Control group | 77 | 92 | 69 | 77 | 85 | 85 | 77 | 85 | 81 |
| FLO | |||||||||
| Intervention group | 86 | 86 | 71 | 86 | 86 | 86 | 79 | 86 | 83 |
| Control group | 77 | 69 | 62 | 62 | 62 | 62 | 62 | 62 | 64 |
MS PRO: multiple sclerosis patient-reported outcome; FLO: Floodlight Open.